Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting up to 20% of the pediatric population associated with alteration of skin and gut microbiome. Probiotics have been proposed for AD treatment. The ProPAD study aimed to investigate the therapeutic effects of the probiotic Lacticaseibacillus rhamnosus GG (LGG) in children with AD.
Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial / Carucci, Laura; Nocerino, Rita; Paparo, Lorella; De Filippis, Francesca; Coppola, Serena; Giglio, Veronica; Cozzolino, Tommaso; Valentino, Vincenzo; Sequino, Giuseppina; Bedogni, Giorgio; Russo, Roberto; Ercolini, Danilo; Berni Canani, Roberto. - In: PEDIATRIC ALLERGY AND IMMUNOLOGY. - ISSN 1399-3038. - 33:8(2022). [10.1111/pai.13836]
Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial
Carucci, Laura;Nocerino, Rita;Paparo, Lorella;De Filippis, Francesca;Coppola, Serena;Giglio, Veronica;Cozzolino, Tommaso;Valentino, Vincenzo;Sequino, Giuseppina;Bedogni, Giorgio;Russo, Roberto;Ercolini, Danilo;Berni Canani, Roberto
2022
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting up to 20% of the pediatric population associated with alteration of skin and gut microbiome. Probiotics have been proposed for AD treatment. The ProPAD study aimed to investigate the therapeutic effects of the probiotic Lacticaseibacillus rhamnosus GG (LGG) in children with AD.| File | Dimensione | Formato | |
|---|---|---|---|
|
Pediatric Allergy Immunology - 2022 - Carucci - Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
879.39 kB
Formato
Adobe PDF
|
879.39 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
